In The News Posted May 3, 2022 Share Posted May 3, 2022 Oramed finaliza la inscripción de pacientes en el estudio central de fase 3 sobre la insulina oral ORA-D-013-1 ORMD-0801 posicionado para ser potencialmente la primera insulina oral aprobada por la FDA para el tratamiento de la diabetes Se ha completado la inscripción de 710 pacientes en...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now